Pure Global
NCT06282055

Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes

Trajectories in Insulin Sensitivity Across Menstrual Cycles in Women With Type 1 Diabetes
DCB Research AG·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus, Type 1
Drug/Device/Intervention
No intervention
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
DCB Research AG
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Mar 01, 2026
Enrollment
250 participants
Primary outcome

Identify different trajectories of insulin sensitivity throughout the menstrual cycle

Summary

Standardized longitudinal data collection of diabetes management relevant factors in women
 with T1D (insulin requirements (insulin pump or smart pen data), glucose variability (CGM
 data), nutritional information, and menstrual cycle information (cycle tracking app, LH
 tests, and premenstrual symptoms)) to identify categories of cycle trajectories.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06282055
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06282055 through Pure Global AI's free database. This phase not specified trial is sponsored by DCB Research AG and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 250 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.